Inside a Mid-size CDMO’s Scale-Up Journey: Lessons from the Frontline
A process that runs cleanly at laboratory or pilot scale doesn’t always behave the same way once it moves into
The Global API Shortage: What It Means for Generic Drug Makers
Generic drug manufacturers run on predictability. Production lines are scheduled weeks or months ahead, procurement teams negotiate contracts against expected
AI Is Quietly Rewriting Drug Discovery — Here’s How
Walk into a modern pharmaceutical research lab today and you won’t necessarily see robots making decisions or algorithms replacing scientists.
Why Biosimilars Are Set to Dominate the Next Decade of Pharma
Biologic medicines have transformed the treatment of many serious and chronic diseases, offering targeted therapies for conditions that were once
EU’s Updated GMP Guidelines Are Changing Supply Chain Audits
Pharmaceutical supply chains have become significantly more interconnected over the past decade. Active pharmaceutical ingredients (APIs), excipients, packaging materials, laboratory
FDA’s New API Sourcing Rules: What Manufacturers Need to Know in 2026
Active Pharmaceutical Ingredients (APIs) form the foundation of every pharmaceutical product, making their sourcing one of the most critical elements